Difference between Thuja Occidentalis & Lapis Albus on tumor.

Thuja Occidentalis vs Lapis Albus on Tumour

Thuja Occidentalis
1. Source: Thuja occidentalis L. (Arbor vitae) — Plant kingdom (1, 2)
2. Miasm: Sycotic
3. Tumour type: Warty growths, condylomata, polypi, spongy tumours, sarcoma, lipoma, fungoid neoplasms (1, 2)
4. Organ affinity: Skin, genito-urinary organs, mucous membranes, glands; lymphomas, CLL, prostate, bladder, breast, uterus, lung (1)
5. Key concomitants: Ill-effects of vaccination, suppressed gonorrhoea, hydrogenoid constitution, tearing pains worse in damp (1, 2)
6. Evidence: Thujone shows anti-proliferative, pro-apoptotic action in cervical, melanoma, and lung cancer cell lines (3, 4, 5)

Lapis Albus
1. Source: Silico-fluoride of calcium (Gastein gneiss) — Mineral kingdom (6, 7, 8)
2. Diathesis: Scrofulous
3. Tumour type: Pre-ulcerative carcinoma, goitre, scrofulous glandular tumours, uterine fibroid, breast carcinoma (6, 7, 8)
4. Organ affinity: Cervical, thyroid and axillary glands, uterus, breast, connective tissue around glands (6, 7, 8)
5. Key concomitants: Burning, shooting, stinging pains in breasts, uterus, cardia, pylorus; elastic pliable glands (not stony); iodine craving (6, 7, 8)
6. Evidence: Clinical / empirical only

Key Difference

1. Kingdom: Plant (Thuja)| Mineral (Lapis Albus)
2. Miasm: Sycotic (Thuja)| Scrofulous (Lapis Albus)
3. Growth character: Warty, condylomatous, fungoid (Thuja)| Glandular, elastic, pre-ulcerative (Lapis Albus)
4. Keynote pain: Tearing, damp aggravation (Thuja)| Burning, shooting, stinging (Lapis Albus)
5. Stage: Any stage (miasm-based) (Thuja)| Pre-ulcerative only (Lapis Albus)
6. Constitution: Hydrogenoid, post-vaccination (Thuja)| Scrofulous, goitre/cretinism region (Lapis Albus)

. One-liner: Thuja = sycotic-miasm tumour (warty, post-vaccination, damp); Lapis Albus = scrofulous-diathesis tumour (glandular, burning, pre-ulcerative).

References (Vancouver)

1. Bagot J-L, Mareau C, Jeulin D, et al. How to prescribe *Thuja occidentalis* in oncology? Analysis of the literature, study of practices and personal experience. Rev d’Homeopathie. 2020;11(4):e75–e88. doi:10.1016/j.revhom.2020.10.004.
2. Boericke W. Thuja occidentalis. In: Pocket Manual of Homoeopathic Materia Medica. 9th ed. Philadelphia: Boericke & Runyon; 1927. Available from: http://www.homeoint.org/books/boericmm/t/thuj.htm
3. Chakraborty S, Ray T, Mitra I, et al. Apoptotic and autophagic death union by *Thuja occidentalis* homeopathic drug in cervical cancer cells with thujone as the bioactive principle. J Integr Med. 2022;20(5):463–472. doi:10.1016/j.joim.2022.06.001.
4. Biswas R, Mandal SK, Dutta S, et al. Thujone-Rich Fraction of *Thuja occidentalis* Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells. Evid Based Complement Alternat Med. 2011;2011:568148. doi:10.1093/ecam/neq042.
5. Pistritto G, Ciotti M, Brandi R, et al. Photodynamic Effects of *Thuja occidentalis* on Lung Cancer Cells. Molecules. 2022;27(16):5164. doi:10.3390/molecules27165164.
6. Clarke JH. Lapis Albus. In: A Dictionary of Practical Materia Medica. London: Homoeopathic Publishing Co.; 1900. Available from: http://www.homeoint.org/clarke/l/lap_a.htm
7. Hering C. Lapis Albus. In: The Guiding Symptoms of Our Materia Medica. Vol. V. Philadelphia: Hahnemann Publishing House; 1887. Available from: http://homeoint.org/hering/l/lap-a.htm
8. Boericke W. Lapis Albus. In: Pocket Manual of Homoeopathic Materia Medica. 9th ed. Philadelphia: Boericke & Runyon; 1927. Available from: http://www.homeoint.org/books/boericmm/l/lap-a.htm